Mollnes TE - Search Results

1

Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass.

Moen O, Høgåsen K, Fosse E, Dregelid E, Brockmeier V, Venge P, Harboe M, Mollnes TE. Moen O, et al. Among authors: mollnes te. Ann Thorac Surg. 1997 Jan;63(1):105-11. doi: 10.1016/s0003-4975(96)00743-6. Ann Thorac Surg. 1997. PMID: 8993250 Clinical Trial.

2

Time for new concepts about measurement of complement activation by cardiopulmonary bypass?

Videm V, Fosse E, Mollnes TE, Garred P, Svennevig JL. Videm V, et al. Among authors: mollnes te. Ann Thorac Surg. 1992 Oct;54(4):725-31. doi: 10.1016/0003-4975(92)91018-5. Ann Thorac Surg. 1992. PMID: 1417231 Clinical Trial.

3

Reduced complement activation with heparin-coated oxygenator and tubings in coronary bypass operations.

Videm V, Svennevig JL, Fosse E, Semb G, Osterud A, Mollnes TE. Videm V, et al. Among authors: mollnes te. J Thorac Cardiovasc Surg. 1992 Apr;103(4):806-13. J Thorac Cardiovasc Surg. 1992. PMID: 1548925

4

Complement activation and bioincompatibility. The terminal complement complex for evaluation and surface modification with heparin for improvement of biomaterials.

Mollnes TE, Videm V, Riesenfeld J, Garred P, Svennevig JL, Fosse E, Hogasen K, Harboe M. Mollnes TE, et al. Clin Exp Immunol. 1991 Oct;86 Suppl 1(Suppl 1):21-6. Clin Exp Immunol. 1991. PMID: 1934602 Free PMC article.

5

Formation of C5a during cardiopulmonary bypass: inhibition by precoating with heparin.

Mollnes TE, Videm V, Götze O, Harboe M, Oppermann M. Mollnes TE, et al. Ann Thorac Surg. 1991 Jul;52(1):92-7. doi: 10.1016/0003-4975(91)91426-v. Ann Thorac Surg. 1991. PMID: 2069469

6

Complement activation with bubble and membrane oxygenators in aortocoronary bypass grafting.

Videm V, Fosse E, Mollnes TE, Garred P, Svennevig JL. Videm V, et al. Among authors: mollnes te. Ann Thorac Surg. 1990 Sep;50(3):387-91. doi: 10.1016/0003-4975(90)90480-t. Ann Thorac Surg. 1990. PMID: 2205161 Clinical Trial.

7

Different oxygenators for cardiopulmonary bypass lead to varying degrees of human complement activation in vitro.

Videm V, Fosse E, Mollnes TE, Ellingsen O, Pedersen T, Karlsen H. Videm V, et al. Among authors: mollnes te. J Thorac Cardiovasc Surg. 1989 May;97(5):764-70. J Thorac Cardiovasc Surg. 1989. PMID: 2709867

8

Effects of methylprednisolone on complement activation and leukocyte counts during cardiopulmonary bypass.

Fosse E, Mollnes TE, Osterud A, Aasen AO. Fosse E, et al. Among authors: mollnes te. Scand J Thorac Cardiovasc Surg. 1987;21(3):255-61. doi: 10.3109/14017438709106035. Scand J Thorac Cardiovasc Surg. 1987. PMID: 2964081

9

Complement activation by extracorporeal circulation: effects of precoating a membrane oxygenator circuit with human whole blood.

Videm V, Fosse E, Mollnes TE, Garred P. Videm V, et al. Among authors: mollnes te. Scand J Thorac Cardiovasc Surg. 1988;22(3):251-6. doi: 10.3109/14017438809106071. Scand J Thorac Cardiovasc Surg. 1988. PMID: 3227328

10

Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass.

Fosse E, Moen O, Johnson E, Semb G, Brockmeier V, Mollnes TE, Fagerhol MK, Venge P. Fosse E, et al. Among authors: mollnes te. Ann Thorac Surg. 1994 Aug;58(2):472-7. doi: 10.1016/0003-4975(94)92231-4. Ann Thorac Surg. 1994. PMID: 8067851

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

625 results

Search Page

Filters